We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£125.20
About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.
£125 today · all-time low £121 (Aug 2026) · usually the usual
Springer Malignant Lymphomas & Hodgkin's Disease: Diagnosis Management
Price data last checked 32 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 59 days · 59 data points (no recent data)
Price data last checked 32 day(s) ago - refreshing...
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 59 days • 3 price levels
Price Analysis
Most common price: £124 (30 days, 50.8%)
Price range: £121 - £125
Price levels: 3 different prices over 59 days
Description
Key Features
Springer-published medical reference providing comprehensive reviews on malignant lymphomas and Hodgkin's disease diagnosis and treatment protocols.
Covers mechanisms of lymphomagenesis and advanced morphologic classification systems essential for accurate disease identification in clinical practice.
Explores cytotoxic agents, biologic therapies, and innovative drug delivery strategies reflecting contemporary lymphoma management approaches.
Volume 66 in the Cancer Treatment and Research series, offering specialist knowledge for internal medicine and oncology practitioners.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 0792321715
- Domain
- Amazon UK
- Release Date
- 31 July 1993
- Listed Since
- 09 December 2006
Barcode
No barcode data available
Similar Products You Might Like
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
Springer
Aggressive Lymphomas (Hematologic Malignancies)
Springer
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
Springer
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
Springer
Hodgkin's and Non-Hodgkin's Lymphoma: Cancer Treatment Research
Springer
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
Humana
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
Springer
Rare Lymphomas (Hematologic Malignancies)
Springer
Wiley Skin Lymphoma: The Illustrated Guide - Medical Text
Wiley
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
Springer
Extranodal Lymphomas: Expert Consult - Online and Print
Elsevier
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
Springer
Springer Malignant Lymphomas and Hodgkin's Disease Book
Springer
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
Springer
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
Springer
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Springer
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
Humana
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
Springer
Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)
Humana
Lymphoma: Methods and Protocols - Volume 971 Research Guide
Humana
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
Springer
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
Springer
T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)
Springer
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
Springer